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Mark J Burish1,2*, Aimee Aysenne1 and Vineeta Singh1Abstract
Background: Acquired hemophilia A (AHA) is a rare coagulopathy linked to a variety of etiologies including
autoimmune diseases, neoplasms, diabetes, respiratory diseases, and the post-partum state. While bleeding in AHA
is often seen in mucocutaneous or intramuscular locations, intracranial and intraspinal bleeds are exceedingly rare.
Case presentation: We report an unusual case of spontaneous multifocal subdural hematomas in a 25 year old
Asian woman with lupus who presented with headache and backache, and was found to have an elevated partial
thromboplastin time (PTT) level and new diagnosis of AHA.
Conclusions: Subdural hematomas as the initial sign of AHA are all but unknown in the medical literature. We
bring this entity to the attention of the neurology community because lumbar puncture and/or conventional
angiogram are often indicated in the work-up of idiopathic multifocal subdural hematomas, but may be dangerous
in patients with AHA.
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Acquired hemophilia A (AHA) is a rare disorder (approxi-
mately 1 in 1 million persons per year) but carries a sig-
nificant mortality of 8–22% [1]. While bleeding in AHA
most commonly involves mucocutaneous or intramuscu-
lar locations, it can also involve the gastrointestinal or
genitourinary tracts [2]. Hemarthrosis, which is consid-
ered a hallmark of congenital Hemophilia, is rarely en-
countered in AHA. While intracranial hemorrhage has
been well documented in congenital hemophilia A [3-6],
there are only a limited number of publications on intra-
cranial bleeds in acquired hemophilia A [7-10], suggesting
that it is a very rare phenomenon. Diagnosis is made
based on the finding of 1) an elevated partial thrombo-
plastin time (PTT) which does not correct after 2 hours
of mixing with normal plasma (mixing study), 2) no ad-
ministration of heparin, which can be determined by a
prolonged thrombin time but normal reptilase time, 3)
negative testing for lupus anticoagulants, and 4) the pres-
ence of an inhibitor as shown on the Bethesda assay,* Correspondence: mark.burish@ucsf.edu
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unless otherwise stated.which mixes serial dilutions of the patient’s blood with
normal plasma [11,12]. The etiology is idiopathic in 50%
and post-partum in 10%, with the remaining 40% covering
a wide spectrum of autoimmune, allergic, neoplastic, dia-
betic, and respiratory diseases [11,13]. Treatment in part
depends on the underlying etiology of the AHA, with
pregnancy- or allergy-related AHA often responding to
steroids or cyclophosphamide and resolving spontan-
eously, tumor-related AHA often depending on treatment
of the malignancy, and autoimmune-related AHA often
requiring stronger immunosuppression and rarely resolv-
ing spontaneously [13].
Case presentation
A 25 year old Asian woman with a history of lupus pre-
sented to the emergency room with headaches not
responding to over the counter analgesics. The head-
aches started 6 days prior, with no reported history of
trauma. She described the headaches as a gradual onset
of intermittent 10/10 sharp right-sided head pain which
lasted for several seconds only, and occurred multiple
times per day. The pain occasionally spread to the right
neck with a pulsating quality but without tinnitus. There
was no postural component, no associated migrainoustd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nophobia, osmophobia, or vision changes), and no tri-
geminal autonomic symptoms (including facial pallor,
facial flushing, lacrimation, or rhinorrhea). In addition,
she occasionally had brief lower back spasmic-type pain
with no radiation. She did not have any symptoms of co-
agulopathy including easy bleeding, GI bleeds, epistaxis,
or hemoptysis. She carried a diagnosis of lupus with dis-
coid rash and arthralgia as predominant symptoms for
which she was taking prednisone 15 mg daily and myco-
phenylate 500 mg BID (she had self-discontinued the
mycophenylate 1 week prior to admission), and a familyFigure 1 Diffuse spontaneous subdural hematoma associated with ac
(A and B), sagittal T1 sequence of the cervical spine (C) and sagittal T1 seq
hematomas indicated by arrows. The patient had subdural hematomas loc
and lumbar (L4-S1) regions.history significant for a sister who died of anemia of an
unknown etiology at the age of 24. Our patient’s neuro-
logic examination was unremarkable.
Given the new onset of severe unilateral headaches
without clear symptoms of a primary headache syn-
drome, head imaging was performed. Brain MRI re-
vealed bilateral infracerebellar and right pre-pontine
extra-axial collections most consistent with hematomas
(Figure 1A and B), and basic laboratory studies were sig-
nificant for an isolated elevation of PTT at 74 with a
normal CBC, chemistry panel, liver panel, INR, and
urine toxicology screen. Additional imaging included aquired hemophilia A. MRI showing coronal brain FLAIR sequence
uence of the lumbar spine (D) demonstrating multiple subdural
ated in the bilateral infracerebellar, cervical (C1-C7, maximal at C6-7),
Burish et al. BMC Research Notes 2014, 7:134 Page 3 of 4
http://www.biomedcentral.com/1756-0500/7/134brain MR venogram with no venous thrombosis, a CT
angiogram with no vasculitis or aneurysms, and a spinal
MRI with additional subdural hematomas in her cervical
and lumbar regions (Figure 1C and D). Work-up of her
elevated PTT revealed a clotting mixing study that failed
to correct with a 1:1 ratio to plasma (suggestive of
the presence of an inhibitor) and an undetectable factor
8 level, consistent with AHA (one month after treat-
ment the factor 8 activity level was 36% with a normal
range of 56–191%). Lupus anticoagulant testing had
previously been performed twice over 6 months, with
an initial indeterminate anti-cardiolipin IgG of 17 that
was normal at 10 on rechecking, and normal levels of
anti-cardiolipin IgM, anti-beta-2-glycoprotein IgG, anti-
beta-2-glycoprotein IgM, Russell Viper Venom Test, and
Russell Viper Venom confirmation testing. Urine preg-
nancy testing was negative and she was not post-partum.
Infectious labs revealed a positive beta-D-glucan and
negative galactomannan, but a brochoalveolar lavage
that was positive only for candida and rare gram-positive
cocci and was negative for acid fast bacilli, other fungi,
and viral cultures. Other infectious testing was negative
including a nasopharyngeal swab for influenza A and B,
urine cultures, blood cultures, histoplasma antigen,
and a hepatitis panel. She was started on recombinantFigure 2 Algorithm for the diagnosis of acquired hemophilia A. Based
hemophilia A can be distinguished from other disorders causing an isolatefactor 7a and rituximab, with repeat imaging showing
resolving hematomas.
Conclusions
Of the multiple etiologies of AHA [11,13], our patient’s
disease was most likely related to her systemic lupus ery-
thematosus. Our patient’s headache and backache de-
scription, specifically the very brief and intermittent
nature of her symptoms, is unusual for pain related to
mass lesions. One previous case report of subdural he-
matomas and AHA described more classic symptoms of
headache and drowsiness [7], but given the paucity of
cases in the literature, it is difficult to say if there is any
characteristic headache associated with AHA.
On initial work-up of our patient, a variety of diagnos-
tic tests were discussed. The differential diagnosis for
non-traumatic intracranial and intraspinal subdural he-
matomas is broad, and etiologies include neoplasms
such as myelodysplastic disorders [14] or meningiomas
[15], infections such as mycotic aneurysms [16], vascular
diseases such as arteriovenous malformations [17], aneu-
rysms [18], or primary CNS vasculitis [19], and coagu-
lopathies such as idiopathic thrombocytopenic purpura
[20]. Thus a thorough investigation for non-traumatic
subdural hematoma may lead to a lumbar puncture or aon the response to mixing tests and phospholipid tests, acquired
d elevation of aPTT.
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bar puncture is not known in patients with AHA, or
even for similar procedures such as epidural injections
in more common coagulopathies [21]. However the risk
of bleeding after lumbar puncture is presumably higher
for patients with untreated AHA than for the general
population. Before performing a lumbar puncture on pa-
tients who are otherwise stable, providers might consider
initiating treatment or awaiting results of the AHA test-
ing. Similarly conventional angiogram may pose un-
necessary risks in patients with AHA, and deferral or
avoidance of angiogram should also be considered, espe-
cially if other vessel imaging such as MRA or CTA is
not suggestive of vascular malformations.
The findings of subdural hematoma with an unex-
plained elevated PTT should prompt further work-up for
AHA with mixing studies at 0.1 and 2 hours, phospholipid
studies for lupus anticoagulant, and the Bethesda assay for
the quantification of inhibitors (Figure 2) [11,12,22]. In pa-
tients with suspected AHA with any pain complaint, such
as lower back pain in our case, imaging should be consid-
ered to look for additional bleeds and to lend stronger
support for starting immediate factor replacement ther-
apy. In the acute setting, if emergent neurosurgical evacu-
ation of these patients is required, factor 7a should be
considered for uncontrolled intra-operative bleeding.
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